The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study
Abstract
Objective To describe the association between apolipoprotein E alleles (epsilon 2, epsilon 3, and epsilon 4), dyslipidemias, and coronary heart disease (CHD). Design Cross-sectional prevalence study. Setting and participants Community-based sample of men (n = 1034) and women (n = 916) aged 40 to 77 years who are participating in a long-term study of cardiovascular disease. Study participants underwent fasting lipid measurements, coronary risk factor determinations, and a comprehensive evaluation for the presence of current or previous CHD. Results Compared with the epsilon 3 allele, the epsilon 4 allele was associated with elevated low-density lipoprotein cholesterol values (> or = 4.14 mmol/L [160 mg/dL]) in women, the epsilon 2 and epsilon 4 alleles were associated with moderately elevated triglyceride values (> or = 2.82 mmol/L [250 mg/dL]) in men, and the epsilon 2 allele was associated with severely elevated triglyceride values (> or = 5.64 mmol/L [500 mg/dL]) in men. The apolipoprotein E alleles were not associated with hypertension, obesity, smoking, or diabetes, but the epsilon 4 allele frequency was reduced in women after 60 years of age. The age-adjusted prevalence of CHD was associated with the epsilon 4 allele in both men (relative odds = 1.53, P = .04) and women (relative odds = 1.99, P = .05). In analyses for women and for both sexes combined, this relation persisted after adjustment by hypertension, smoking, obesity, diabetes, high-density lipoprotein cholester…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The apoE4 isoform has been linked with increased levels of LDL and has been demonstrated to be a risk factor for cardiovascular disease (Song et al., 2004; Wilson et al., 1994).”
From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Wilson et al., 1994
In the citing paper
“a decreased risk of coronary artery disease (unless it is associated with type III hyperlipoproteinemia), 42,43”
From Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein E (1996) · cites this paper as [43]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,154
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Cited by
Sorted by citations
Items 401–473 of 473
Modeling the Effects of Genetic Factors on Late-Onset Diseases in Cohort Studies
Glickman, M. E., & GAGNON, D. R. (2002) · Lifetime Data Analysis · doi:10.1023/a:1015880003274 · Cited by 3
Lipoprotein measurements—setting priorities
Wilson, P. W. F. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00687-2 · Cited by 3
Self-citationApolipoprotein E genotype and coronary heart disease
Batalla, A., Álvarez, R., Hevia, S., Reguero, J. R., & Coto, E. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01072-x · Cited by 3
Genetic Testing in the Early Diagnosis of Alzheimer’s Disease
Blacker, D., & Tanzi, R. E. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-005-6_5 · Cited by 3
CLINICAL APPLICATIONS | Electrophoresis
Tissot, J., Layer, A., Schneider, P., & Henry, H. (2000) · Elsevier eBooks · doi:10.1016/b0-12-226770-2/07561-x · Cited by 3
Longevidad y genotipo apoE 2/3 en una familia de Tierra de Campos
Gil, F. J. M., Ramos-Sánchez, M. C., Cerón-Fernández, A., & Arranz-Peña, M. L. (2010) · Revista Clínica Española · doi:10.1016/j.rce.2010.02.012 · Cited by 2
Craig, I. H., & Thompson, P. L. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7295-3927-2.10007-7 · Cited by 2
Blood Brain Barrier Dysfunction and Cerebrovascular Degeneration in Alzheimer’s Disease
Kalaria, R. N. (2000) · Springer eBooks · doi:10.1007/978-94-017-1007-7_11 · Cited by 2
Aditya, C. R., Sattaru, N. C., Gopal, K., Rahul, R., Shekara, G. C., Nasif, O., Alharbi, S. A., Raghavan, S. S., & Jayadhas, S. A. (2022) · BioMed Research International · doi:10.1155/2022/2632770 · Cited by 2
RetractedCLINICAL APPLICATIONS | Electrophoresis
Tissot, J., Prudent, M., Lion, N., & Henry, H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.04704-1 · Cited by 2
Genetic Markers in Cardiovascular Disease
Sabatine, M. S. (2006) · Humana Press eBooks · doi:10.1007/978-1-59745-051-5_34 · Cited by 1
Role of Apolipoprotein E Genotype in Coronary Artery Disease
Tziakas, D. N., & Chalikias, G. K. (2007) · Future Cardiology · doi:10.2217/14796678.3.5.537 · Cited by 1
Primary disorders of LDL-cholesterol metabolism
Rosenson, R. S., de Ferranti, S. D., Freeman, M. W., & Saperia, G. M. (2011) · Cited by 1
Nock, N. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_12 · Cited by 1
Boulenouar, H., Lardjam-Hetraf, S. A., Ouhaïbi-Djellouli, H., Meroufel, D. N., FODIL, F. Z., Hamani-Medjaoui, I., Saïdi‐Mehtar, N., Houti, L., & Médiène-Benchekor, S. (2020) · African Health Sciences · doi:10.4314/ahs.v20i2.25 · Cited by 1
Kamble, P. (2020) · The Medical Journal of Basrah University · doi:10.33762/mjbu.2020.127936.1030 · Cited by 1
Stengård, J., Pekkanen, J., Ehnholm, C., et al. (1996) · Human Genetics · doi:10.1007/s004390050115 · Cited by 1
Nock, N. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_12 · Cited by 1
Epidemiology of Blood Lipids and Lipoproteins
Wilson, P. W. F. (2015) · Contemporary Endocrinology · doi:10.1007/978-1-60761-424-1_2 · Cited by 1
Self-citationDie Wirkung von VLDL-Isoformen auf die flussabhängige Dilatation an Koronararterien des Menschen
Schlangen, J. (2010) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-15060 · Cited by 1
Rodrigo, E., González‐Lamuño, D., Isla, D., Fernández‐Fresnedo, G., Ruiz, J. C., Piñera, C., Herráez, I., & Arias, M. (2001) · Transplantation Proceedings · doi:10.1016/s0041-1345(01)02585-4 · Cited by 1
Shin, M., Eun Young Cho, Park, H., Cho, H. K., Lee, J. H., & Jang, Y. (2003) · Nutrition Research · doi:10.1016/s0271-5317(03)00153-2 · Cited by 1
APOLIPOPROTEIN E AND INCIDENT HYPERTENSION: THE BAMBUÍ HEALTH AGING STUDY
Lima‐Costa, M. F., Peixoto, S. V., Fuzikawa, A. K., Taufer, M., & Moriguchi, E. H. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01406.x · Cited by 1
Apolipoprotein E Polymorphism in Patients with Myocardial Infarction
Jeong, H. S., Kim, S.-K., Lee, S. C., Bang, D. W., Shin, W. Y., On, Y. K., Choe, S. C., Kim, C. H., Choi, T. M., Hyun, M. S., et al. (2002) · Korean Circulation Journal · doi:10.4070/kcj.2002.32.1.31 · Cited by 1
Xanthomes tubéreux révélant une hypercholestérolémie familiale homozygote
Hammami, H., Benmously, R., Marrak, H., Debbiche, A., Souissi, A., Ayed, M. B., Fenniche, S., & Mokhtar, I. (2008) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2008.03.030 · Cited by 1
The Mediterranean Diet and Coronary Heart Disease
Yiannakouris, N., Hourdakis, M., & Zampelas, A. (2001) · Modern nutrition · doi:10.1201/9781420042221.ch11 · Cited by 1
Understanding Incidence and Prevalence Rates in Mixed Dementia
Gunstad, J., & Browndyke, J. N. (2005) · Humana Press eBooks · doi:10.1385/1-59259-824-2:245 · Cited by 1
Ethnic Variation in the Association Between APOE-ε4 and Alzheimer’s Disease: A Follow-up Study
Maestre, G. E., Schofield, P. W., Chun, M. R., Tang, M. ‐., Tycko, B., & Mayeux, R. P. (1996) · Springer eBooks · doi:10.1007/978-3-642-80109-9_15 · Cited by 1
Genes That Modify Susceptibility to Atherosclerosis: Targets for Drug Action
Knowles, J. W. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06214-2_4
Sierra, C. (2002) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
The road from atherosclerosis to myocardial infarction : Studies in an experimental model
Hemdahl, A.-L. (2005) · Figshare
Simmons, C. R. (2011) · UKnowledge (University of Kentucky)
Gopinathannair, R. (2004) · University Libraries (University of Maryland)
Do genetic determinates of ischaemic heart disease imply that prevention may become more difficult?
Tonstad (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00273.x
Kim, S.-W., & Yoo, M. (2010) · Journal of Life Science · doi:10.5352/jls.2010.20.4.584
Serum lipids and gender affect trajectories of cognitive function in late life
Wellington, C. L. (2010) · Clinical Lipidology · doi:10.2217/clp.10.46
What do we know about apolipoprotein E and the prevention of cardiovascular disease?
Tan, C. T., & Tai, E. S. (2004) · Drug Development Research · doi:10.1002/ddr.10357
Calcitropic Hormones and Systemic Factors of Vascular Calcification
Oh, K. W., & Kang, M. I. (2005) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2005.20.6.561
Polymorphism of Apolipoprotein E
Kim, C. J. (1997) · Korean Circulation Journal · doi:10.4070/kcj.1997.27.3.275
Apo E polymorphism among Egyptian patients with essential hypertension
El-Abd, D. M., Essawi, M. L., Soliman, H. N., Mohy, A. M., Mandour, I. A., Sedky, N. M., & ElFaramawy, A. (2012) · Comparative Clinical Pathology · doi:10.1007/s00580-012-1476-8
Apolipoproteins and β Amyloid Transport Pathway
Kamino, K., Kida, T., Tanaka, T., Tanii, H., Okochi, M., Kudo, T., Kobayashi, T., & Takeda, M. (2002) · Psychogeriatrics · doi:10.1111/j.1479-8301.2002.tb00078.x
Bibliography NIA/AlzA Conference on Apolipoprotein E Genotyping in Alzheimer's Disease
Kwon, Y. J., Tsai, J., & Relkin, N. R. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32609.x
Kwon, C.-H., Rhee, E., Kim, S.-Y., Kim, E. R., Chon, C. U., Jung, C., Yun, J.-H., Kim, B. J., Sung, K., Kim, B.-S., et al. (2006) · The Journal of Korean Diabetes Association · doi:10.4093/jkda.2006.30.2.122
Aspectos epidemiológicos de la enfermedad cardiovascular: factores de riesgo a la luz de
Ignacio, N., Gómez, J. M. P., & Torres, Y. (2004) · Dialnet (Universidad de la Rioja)
Genetic and Expressional Studies of Alzheimer's Disease
Iivonen, S. (2005)
Genetic and immunological risk factors and carotid artery atherosclerosis
Karvonen, J. (2004)
Genetics of Common Lipid Disorders
Nock, N. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_12-1
Ocular biomarkers for early detection and monitoring of Alzheimer's disease
Frost, S. M. (2013) · UWA Profiles and Research Repository (UWA)
Association of Apolipoprotein E Genotype with Early and Advanced Atherosclerotic Lesions
Ilveskoski, E. (2001) · Tampere University Institutional Repository (Tampere University)
Genetische Aspekte der koronaren Herzerkrankung bei Patienten mit Hyperlipoproteinämie
Medizin, I., & Medizin, A. I. (2005)
The Newer Coronary Risk Factors
Wilson, P. W. F. (2003) · doi:10.1007/978-1-4615-6484-3_10
Self-citationGene-Diet Interactions, Blood Lipids, and Cardiovascular Disease Risk
Ordovás, J. M. (2006) · CRC Press eBooks · doi:10.1201/9781420005905.ch2
Genomics, Nutrigenomics, Nutrigenetics, and the Path of Personalized Medicine
Culp, T. M., & Hanaway, P. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-2333-5.00016-x
Osteoporosis and Apolipoprotein E Genotype in Older Adults: The
Barrett-Connor, E. L., Schneider, D. L., Morin, P. A., et al. (2001)
Genomics, Nutrigenomics, and the Promise of Personalized Medicine
Orr, B. J., Culp, T. M., & Hanaway, P. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00015-7
Park, J.-H., Kim, Y., & Kim, J.-P. (2020) · Korean Leprosy Bulletin · doi:10.33161/klb.2020.53.1.23
The Biological Mechanism of Aging: Is It Still an Enigma?
Masoro, E. J. (1998) · Journal of Advancement in Medicine · doi:10.1023/a:1023395002361
Genetic Polymorphisms and Arterial Thrombosis
Margaglione, M., Grandone, E., Mancini, F. P., & Minno, G. D. (1998) · Springer eBooks · doi:10.1007/978-1-4899-1483-5_22
Le, N., & Brown, W. V. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-878-6_28
Polymorphisms in Cardiovascular Medicine
Cooper, D. N., & Cockcroft, J. (2006) · CRC Press eBooks · doi:10.3109/9781420016697-12
Triglyceride-Rich Lipoproteins
Le, N., & Brown, W. V. (2000) · doi:10.1007/978-1-4757-9310-9_5
Triglyceride-Rich Lipoproteins
Le, N., & Brown, W. V. (2003) · doi:10.1007/978-1-4615-6484-3_5
(2007) · Elsevier eBooks · doi:10.1016/b978-012373657-4/50008-8
Biochemistry, C. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(02)80731-0
Apoprotein e and lipoprotein (a) genetics as markers for coronary heart disease
Cerqueira, E. M., Saldanha, A. L. R., Gasparoto, A. L. V., Margeotto, A. P. P., Daniel, N. R., Tibiriçá, R. I., de Oliveira, R. C. S., Fakhouri, T. L. B., & Martinez, T. L. D. R. (2023) · Journal of Cardiology & Current Research · doi:10.15406/jccr.2023.16.00587
Clinical Presentations and Coronary Plaque Characteristics
Vergallo, R., & Jang, I. (2014) · Springer eBooks · doi:10.1007/978-3-319-10801-8_6
Wilson, P. W. F. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5839-6_6
Self-citationGenetische Aspekte der koronaren Herzerkrankung bei Patienten mit Hyperlipoproteinämie
Medizin, I., & Medizin, A. I. (2005)
Metadata
- Authors
- Wilson, P. W. F.
- Corresponding author
- Wilson, Peter W. F.
- ORCID
- Wilson, Peter W. F.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1994-12-07
- Volume
- 272
- Issue
- 21
- Pages
- 1666
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4237709179
- Cited by
- 468
- References
- 59
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 10 · 2022: 3 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 2 · 2017: 6 · 2016: 7 · 2015: 7 · 2014: 7 · 2013: 14 · 2012: 9
- FWCI
- 21.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- apolipoprotein E, apolipoprotein E ε4 allele, dyslipidemia, coronary artery disease, LDL cholesterol, triglycerides, sex differences, genetic risk factors, Framingham Offspring Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review